J&J Propulsid Compassionate IND Program Expands To Allow Emergency Use

Janssen is adding three IND treatment protocols to its limited access program for Propulsid (cisapride).

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet